Bifidobacterium Breve
Product description
- Specification: 100 billion cfu/gram (highest potency 200 billion cfu/g)
- Bifidobacterium Breve was first isolated from the feces of healthy breastfed infants by pediatrician Henry Tissier at the Pasteur Institute in France in 1899. It is native beneficial bacterium in the human gut.
- Main characteristics of Bifidobacterium breve:*Strong acid resistance *Regulating gut microbiota *Great acid production ability *Improve sleep quality *Strong adhesion performance *Effectively enhance immunity *Intestinal colonization ability *Improve bioavailability *Promote allergic populations
Company information
Bifidobacterium Breve
Specifications
Categories | Probiotics |
---|---|
Supplied from | China |
Product Applications | Dietary Supplements; Food Supplements |
Product Certifications | Quality assurance |
Bifidobacterium Breve